The e-mentorship program by the Society of NeuroInterventional Surgery (SNIS) is dedicated to advancing the field of neuroendovascular medicine through a structured and interactive learning experience. This program aims to foster the exchange of specialized knowledge and expertise between seasoned professionals and emerging practitioners.

Goal:  to provide expert mentorship from senior SNIS members to the global community of neurointerventional surgeons.

Through this program, senior and experienced mentors will engage in the following activities with their mentees:

• Sharing Educational Cases: Mentors will present a diverse range of real-time neuroendovascular cases, providing mentees with a comprehensive understanding of various scenarios, treatment strategies, and outcomes.
• Guided Learning: Mentors will offer personalized guidance, helping mentees navigate complex clinical situations, develop critical thinking skills, and apply theoretical knowledge in practical settings.
• Knowledge Exchange: The program promotes a two-way exchange of knowledge, where mentors and mentees can discuss the latest advancements, research findings, and best practices in neuroendovascular care.
• Professional Development: By fostering a mentor-mentee relationship, the program supports the professional growth of mentees, preparing them for leadership roles and encouraging continuous learning and improvement.
• Community Building: The e-mentorship program aims to build a strong, interconnected community of neuroendovascular specialists who are committed to excellence in patient care and innovation in the field.

The e-mentorship program is designed to create a supportive and collaborative learning environment that enhances the skills and knowledge of both mentors and mentees, ultimately contributing to the advancement of neuroendovascular medicine.

To apply to serve as an e-mentor, please complete this application.

To apply to be an e-mentee, please complete this application.

This program is supported financially from a generous and unrestricted grant from Johnson & Johnson MedTech Neurovascular.